Fenopure

Fenopure is a hybrid cannabis strain with up to 0.2% THC, known for its non-intoxicating effects and earthy and fruity flavor profile.

Fenopure is a pioneering CBG-dominant cannabis strain developed by the Swiss breeding company Fenocan. This strain represents one of the first commercially available CBG-dominant resinous varieties worldwide, containing between 6-16% cannabigerol (CBG) while maintaining extremely low THC levels below 0.2%. Developed using SMART (Selection with Markers Advanced Reproductive Technologies) breeding techniques, Fenopure combines traditional breeding methods with genomic knowledge to achieve optimal cannabinoid profiles. The strain is a well-balanced hybrid with approximately 60% sativa and 40% indica genetics, designed specifically for legal cultivation in most countries due to its minimal THC content.

Fenopure produces long and bushy plants with resinous, bright flowers that exhibit intense earthy and fruity aromatic profiles. The strain is particularly notable for its high CBG content, as CBG is often called the 'mother of all cannabinoids' since it serves as a precursor to CBD, CBC, and THC. The variety has been specifically bred to maintain CBG levels while preventing the typical conversion to other cannabinoids that occurs during plant maturation. This unique cannabinoid profile makes Fenopure valuable for both medical research applications and consumers seeking the potential therapeutic benefits of CBG without psychoactive effects. The strain's development reflects the growing interest in minor cannabinoids and represents a significant advancement in hemp breeding technology.